LCN2 and inflammatory breast carcinoma: Studies in our laboratory have demonstrated that siRNA-mediated knockdown of LCN2 can significantly inhibit cell proliferation and invasion in IBC cells and also induce cell cycle arrest and increased apoptosis [6].